COXFA4L2 and cancer: Regarding clinical prognosis, studies have shown that high expression of NDUFA4L2 is closely associated with microsatellite stability and cancer encapsulation in HCC and with a poor prognosis of HCC patients, indicating its potential value in the clinical diagnosis and treatment of HCC.